LLY - ELI LILLY & Co
821.46
-2.160 -0.263%
Share volume: 2,855,292
Last Updated: 05-05-2025
Pharmaceutical Products/Pharmaceutical Preparations:
-0.08%
PREVIOUS CLOSE
CHG
CHG%
$823.62
-2.16
0.00%
View ratios
| Fiscal Date | 06-30-2023 | 09-30-2023 | 12-31-2023 | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | |
| Report Date | 08-08-2023 | 11-02-2023 | 02-19-2025 | 04-30-2024 | 08-08-2024 | 10-30-2024 | 02-19-2025 | 05-01-2025 | |
| Total revenue | 8.312 B | 9.499 B | 9.353 B | 8.768 B | 11.303 B | 11.439 B | 13.533 B | 12.729 B | |
| Cost of revenue | 1.807 B | 1.860 B | 1.788 B | 1.674 B | 2.170 B | 2.171 B | 2.404 B | 2.224 B | |
| Gross profit | 6.505 B | 7.639 B | 7.565 B | 7.095 B | 9.133 B | 9.268 B | 11.129 B | 10.504 B | |
| 17.43% | -0.96% | -6.22% | 28.73% | 1.49% | 20.08% | -5.61% | |||
| Operating expenses | 4.282 B | 4.213 B | 5.110 B | 4.586 B | 4.983 B | 7.660 B | 5.636 B | 6.774 B | |
| Selling general and admin | 1.925 B | 1.804 B | 1.925 B | 1.952 B | 2.117 B | 2.100 B | 2.425 B | 2.469 B | |
| Research and development | 2.357 B | 2.409 B | 3.185 B | 2.633 B | 2.866 B | 5.561 B | 3.212 B | 4.305 B | |
| Total expenses | 6.089 B | 6.073 B | 5.178 B | 4.586 B | 5.418 B | 7.742 B | 5.980 B | 6.809 B | |
| -0.27% | -14.75% | -11.44% | 18.15% | 42.90% | -22.76% | 13.86% | |||
| Operating income | 2.223 B | 3.426 B | 2.388 B | 2.509 B | 3.715 B | 1.526 B | 5.149 B | 3.695 B | |
| Ebit | 2.223 B | 3.426 B | 2.509 B | 2.536 B | 3.517 B | 1.588 B | 5.039 B | 3.456 B | |
| Pretax income | 2.089 B | 427.200 M | 2.509 B | 2.536 B | 3.517 B | 1.588 B | 5.039 B | 3.456 B | |
| -79.55% | 487.27% | 1.09% | 38.69% | -54.84% | 217.22% | -31.41% | |||
| Income tax | 325.700 M | 484.600 M | 319.100 M | 293.200 M | 550.200 M | 618.100 M | 628.900 M | 696.800 M | |
| Net income basic | 1.763 B | -57.400 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| -103.26% | 100.00% | ||||||||
| Net income | 1.763 B | -57.400 M | 2.190 B | 2.243 B | 2.967 B | 970.300 M | 4.410 B | 2.759 B | |
| -103.26% | 3,914.81% | 2.43% | 32.28% | -67.30% | 354.48% | -37.43% |
